MICHELLE MCCLELLAN: Open Payments
NPI 1619608924 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 6 payments from 4 companies in 2025. Trend: 2023 $66 · 2024 $179 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $145 |
| Janssen Pharmaceuticals, Inc | 2 | $143 |
| Neurocrine BioSciences, Inc. | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $81 |
Products named: UZEDY, INVEGA SUSTENNA, INGREZZA, COBENFY.
Industry payments across TX — which companies pay providers there.
